Sanjay Adhikary Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2026 Last refreshed 2026-04-25

unknown

2 h-index 8 pubs 12 cited

Biography and Research Information

OverviewAI-generated summary

Sanjay Adhikary's research focuses on the investigation of potential therapeutic agents, particularly in the context of melanoma treatment. His recent work has explored the in vitro antimicrobial properties of plant extracts, specifically from Verbena officinalis, and the synthesis of novel thiazole-fused bisnoralcohol derivatives. Adhikary has also studied thiazole-fused androstenone and ethisterone derivatives as inhibitors of the beta- and gamma-actin cytoskeleton, aiming to develop new treatments for melanoma tumors. He has published seven papers with a total of 10 citations and an h-index of 2. His collaborations include researchers from Arkansas State University and the University of Arkansas for Medical Sciences, with whom he has co-authored multiple publications.

Metrics

  • h-index: 2
  • Publications: 8
  • Citations: 12

Selected Publications

  • 691 ATF6 activation promotes ICB response in melanoma (2025)
  • Correction: Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2025)
  • Thiazole-fused androstenone and ethisterone derivatives: potent β- and γ-actin cytoskeleton inhibitors to treat melanoma tumors (2024)
  • Efficient Synthesis of Thiazole-Fused Bisnoralcohol Derivatives as Potential Therapeutic Agents (2024)
    3 citations DOI OpenAlex
  • In Vitro Antimelanoma Properties of Verbena officinalis Fractions (2022)
    7 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

24 Collaborators 6 Institutions 2 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics